🔗 Share this article

Ex-government leader Rishi Sunak has intensified his call for a focused screening programme for prostate cancer.

In a recent interview, he expressed being "convinced of the critical importance" of establishing such a programme that would be economical, deliverable and "save countless lives".

His comments emerge as the UK National Screening Committee reevaluates its decision from the previous five-year period not to recommend regular testing.

Media reports suggest the committee may continue with its current stance.

Athlete Contributes Voice to Campaign

Champion athlete Chris Hoy, who has advanced prostate gland cancer, wants middle-aged males to be checked.

He proposes decreasing the eligibility age for obtaining a PSA laboratory test.

Presently, it is not automatically provided to healthy individuals who are under 50.

The prostate-specific antigen screening remains controversial however. Readings can elevate for causes besides cancer, such as bacterial issues, causing misleading readings.

Critics maintain this can result in unnecessary treatment and side effects.

Targeted Screening Proposal

The proposed screening programme would focus on males between 45 and 69 with a family history of prostate gland cancer and black men, who face increased susceptibility.

This group comprises around 1.3 million individuals males in the UK.

Organization calculations indicate the system would cost twenty-five million pounds annually - or about eighteen pounds per participant - comparable to intestinal and breast testing.

The projection involves 20% of qualified individuals would be notified annually, with a 72% uptake rate.

Diagnostic activity (imaging and tissue samples) would need to increase by twenty-three percent, with only a reasonable increase in medical workforce, based on the report.

Medical Professionals Response

Some medical experts remain sceptical about the benefit of screening.

They assert there is still a chance that individuals will be intervened for the cancer when it is not absolutely required and will then have to endure complications such as incontinence and erectile dysfunction.

One leading urological professional remarked that "The issue is we can often identify disease that might not necessitate to be treated and we end up causing harm...and my concern at the moment is that negative to positive equation requires refinement."

Individual Perspectives

Patient voices are also shaping the discussion.

One example concerns a 66-year-old who, after seeking a prostate screening, was diagnosed with the cancer at the age of 59 and was told it had metastasized to his pelvis.

He has since experienced chemical therapy, radiation treatment and hormone treatment but is not curable.

The patient endorses examination for those who are at higher risk.

"This is crucial to me because of my boys – they are in their late thirties and early forties – I want them screened as promptly. If I had been examined at fifty I am sure I would not be in the situation I am currently," he commented.

Future Actions

The National Screening Committee will have to weigh up the data and viewpoints.

Although the recent study says the consequences for staffing and availability of a screening programme would be manageable, some critics have argued that it would divert imaging resources from patients being managed for other conditions.

The current dialogue highlights the complicated balance between prompt identification and possible overtreatment in prostate gland cancer management.